Boston Pharmaceuticals products

BOS-704 is a ghrelin O-acyl transferase inhibitor with therapeutic potential for multiple indications.

BOS-421 is a highly selective, brain penetrant RIPK1 inhibitor.

BOS-228 is a novel monobactam for infections caused by multidrug-resistant carbapenem-resistant Enterobacteriaceae.

BOS-572 is a broad-spectrum serine beta-lactamase inhibitor (BLI) of the diazabicyclooctane (DBO) class.

BOS161721 (avizakimab) is a fully human anti-IL-21 antibody.